Pharmaceuticals constitute about 75% of the topics being actively tracked in the Horizon Scanning System; devices constitute about 19%. Download the free report, “Report of a Pilot Project: Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports.”
The range of interventions identified in the study spanned broad clinical areas including cancer, cardiopulmonary disease, infectious disease, mental illness, functional disability and limitations, and obesity.
ECRI Institute was selected by AHRQ to develop the Healthcare Horizon Scanning System in 2010, and continues to publish new content from the system several times a year. The Healthcare Horizon Scanning System is an early alerting system and strategic planning tool that identifies novel drugs, devices, and procedures in development that are intended to address important healthcare needs.
Ad Statistics
Times Displayed: 49670
Times Visited: 1409 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
For questions about the report or the Healthcare Horizon Scanning System, please contact ECRI Institute by telephone at (610) 825-6000, ext. 5440; by e-mail at htais@ecri.org; by fax at (610) 834-1275; or by mail at 5200 Butler Pike, Plymouth Meeting, PA 19462-1298, USA.
Social Sharing
ECRI Institute’s Horizon Scanning System analysis reveals possible $80b 1-year spend on new drug and device therapies ly.ecri.org/1SCmme
Horizon Scanning System analysis by @ECRI_Institute: possible $80b 1yr spend on new drug/device therapies @AHRQNews
About ECRI Institute
ECRI Institute (www.ecri.org), a nonprofit organization, dedicates itself to bringing the discipline of applied scientific research to healthcare to discover which medical procedures, devices, drugs, and processes enable improved patient care. As pioneers in this science for nearly 50 years, ECRI Institute marries experience and independence with the objectivity of evidence-based research. Strict conflict-of-interest guidelines ensure objectivity. ECRI Institute is designated an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality. ECRI Institute PSO is listed as a federally certified Patient Safety Organization by the U.S. Department of Health and Human Services. Find ECRI Institute on Facebook (www.facebook.com/ECRIInstitute) and on Twitter (www.twitter.com/ECRI_Institute).
For more information, contact:
Laurie Menyo, Director of Public Relations and Marketing Communications
(610) 825-6000, ext. 5310
lmenyo@ecri.org
Back to HCB News
